Civik Thomas 4
4 · Pyxis Oncology, Inc. · Filed Apr 4, 2022
Insider Transaction Report
Form 4
Civik Thomas
DirectorInterim CEO
Transactions
- Award
Common Stock
2022-03-31+66,831→ 66,831 total
Holdings
- 15,700(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.
- [F2]These shares are held directly by the Civik Family Trust, a revocable trust for which the Reporting Person and his spouse are the grantors.